Experimental Drug May Address Working Memory Impairments That Occur In Schizophrenia
Monday, December 1, 2008 - 12:49
in Health & Medicine
In one of the first instances of targeted drug design in psychiatric treatment, researchers have found an experimental agent that shows promise in addressing working memory impairments that occur in the schizophrenia.